Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
205.4 USD | -1.29% | -5.05% | -11.34% |
04:55pm | UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating | MT |
05-07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
- Stock Market
- Equities
- MDGL Stock
- News Madrigal Pharmaceuticals, Inc.
- MarketScreener Strategies